Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system

被引：28

作者：

Kahl, Kai G. ^{[1
,2
]}

Westhoff-Bleck, Mechthild ^{[3
]}

Krueger, Tillmann H. C. ^{[1
]}

机构：

[1] Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany

[2] AGNP, Working Grp Polypharm, Munich, Germany

[3] Dept Cardiol & Angiol, Hannover, Germany

来源：

VASCULAR PHARMACOLOGY | 2018年 / 100卷

关键词：

Cardiovascular effects; Vascular system; Antidepressants; Antipsychotics; Morbidity; Mortality; QTc prolongation; Weight gain; Diabetes; CORRECTED QT INTERVAL; SEVERE MENTAL-ILLNESS; EXCESS MORTALITY; VENOUS THROMBOEMBOLISM; ATYPICAL ANTIPSYCHOTICS; CARDIOVASCULAR RISK; CEREBROVASCULAR EVENTS; ELDERLY-PATIENTS; ADVERSE EVENTS; BLOOD-PRESSURE;

D O I：

10.1016/j.vph.2017.09.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Psychopharmacological treatment with antipsychotic drugs is an essential part of guideline-based treatment strategies in psychotic disorders, such as schizophrenia, schizoaffective disorders, and delusional disorders. Other mental disorders frequently treated with antipsychotic drugs are bipolar disorders, and major depressive disorder. Furthermore, antipsychotic drugs are often given in emergency and surgical units for the treatment of metabolic or postoperative delirium. Antipsychotic drugs can exert direct and indirect effects on the vascular system, potentially leading to severe complications such as thromboembolism. Therefore, knowledge of vascular side effects of antipsychotic drugs is important for clinicians. This clinical orientated review article covers direct and indirect effects of antipsychotics on the vascular system.

引用

页码：20 / 25

页数：6

共 129 条

[81] Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia Number Needed to Harm [J].

Maust, Donovan T. ;

Kim, Hyungjin Myra ;

Seyfried, Lisa S. ;

Chiang, Claire ;

Kavanagh, Janet ;

Schneider, Lon S. ;

Kales, Helen C. .

JAMA PSYCHIATRY, 2015, 72 (05) :438-445

[82] Diet, smoking and cardiovascular risk in people with schizophrenia - Descriptive study [J].

McCreadie, RG .

BRITISH JOURNAL OF PSYCHIATRY, 2003, 183 :534-539

[83]

Meyer-Massetti Carla, 2010, J Hosp Med, V5, pE8, DOI 10.1002/jhm.691

[84] Excess Mortality in Bipolar Disorders [J].

Miller, Christopher ;

Bauer, Mark S. .

CURRENT PSYCHIATRY REPORTS, 2014, 16 (11)

[85] Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis [J].

Mitchell, Alex J. ;

Vancampfort, Davy ;

Sweers, Kim ;

van Winkel, Ruud ;

Yu, Weiping ;

De Hert, Marc .

SCHIZOPHRENIA BULLETIN, 2013, 39 (02) :306-318

[86] Severe mental illness and risk of cardiovascular disease [J].

Newcomer, John W. ;

Hennekens, Charles H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (15) :1794-1796

[87] Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden [J].

Nordentoft, Merete ;

Wahlbeck, Kristian ;

Hallgren, Jonas ;

Westman, Jeanette ;

Osby, Urban ;

Alinaghizadeh, Hassan ;

Gissler, Mika ;

Laursen, Thomas Munk .

PLOS ONE, 2013, 8 (01)

[88] Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors [J].

Norgaard, Ane ;

Jensen-Dahm, Christina ;

Gasse, Christiane ;

Hansen, Elsebet Steno ;

Waldemar, Gunhild .

JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (02) :707-716

[89] Left atrial thrombosis associated with antipsychotic drugs [J].

Numata, S ;

Kato, O ;

Misawa, H ;

Tokuda, H ;

Kasahara, T ;

Ohmori, T .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (01) :153-155

[90] Premature Mortality Among Adults With Schizophrenia in the United States [J].

Olfson, Mark ;

Gerhard, Tobias ;

Huang, Cecilia ;

Crystal, Stephen ;

Stroup, T. Scott .

JAMA PSYCHIATRY, 2015, 72 (12) :1172-1181

← 4 5 6 7 8 9 10 11 12 13 →